SCHEMBL8457350

SCHEMBL8457350

CCOC(OC)Oc1cc(C23CC4CC(CC(C4)C2)C3)cc(-c2cccc3ccccc23)c1C(=O)Nc1ccc(OC(C)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HIF1A Q16665 5/20 0.34
EPAS1 Q99814 1/20 0.34
MAPT P10636 2/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
AHR P35869 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TSHR P16473 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458190 0.92 DEGS1 (0.35) EPHX2MEN1KMT2AHIF1AEPAS1
SCHEMBL8458404 0.83 HIF1A (0.38) EPHX2MEN1KMT2AHIF1AEPAS1
SCHEMBL8459014 0.80 CNR2 (0.31) HIF1ACNR2
SCHEMBL8458293 0.74 IKBKB (0.39) MEN1KMT2AHIF1AEPAS1NPC1
SCHEMBL7926633 0.72 RARB (0.43) EPHX2MEN1KMT2AMAPTNPC1
SCHEMBL8911209 0.70 RARA (0.41) MEN1KMT2ANPC1RAB9ACNR2
SCHEMBL8458292 0.69 IKBKB (0.41) KMT2AHIF1AEPAS1CNR2
SCHEMBL8457675 0.69 NPC1 (0.41) EPHX2MEN1KMT2AHIF1AEPAS1
SCHEMBL7926531 0.68 RARB (0.46) EPHX2MEN1KMT2AMAPTTP53
SCHEMBL8616385 0.67 S1PR1 (0.39) EPHX2MEN1KMT2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed